(Q45974480)

18 December 2017

meta-analysis

0 references

title

Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis. (English)

1 reference

18 December 2017

0 references

0 references

1 reference

Shiyao He

1

1 reference

18 December 2017

Yu-hong Tang

2

1 reference

18 December 2017

Guobin Zhao

3

1 reference

18 December 2017

Xiaolong Yang

4

1 reference

18 December 2017

Dehou Wang

5

1 reference

18 December 2017

Ye Zhang

6

1 reference

18 December 2017

publication date

4 October 2013

1 reference

18 December 2017

published in

Tumor Biology

1 reference

18 December 2017

volume

35

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

2095-2102

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-1278-x

exact match

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Effects of PPAR agonists on proliferation and differentiation in human urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1278-X

Pioglitazone and bladder cancer: a propensity score matched cohort study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24092576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24092576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24092576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-1278-X

1 reference

18 December 2017

Dimensions Publication ID

1033050600

0 references

1 reference

18 December 2017